Orphenadrine Citrate
Product Images NDC 0115-2011

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 0115-2011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2 (Orphenadrine Citrate Extended Release Tablets 1)

Label for Orphenadrine Citrate Extended-Release Tablets 100 mg by Amneal Pharmaceuticals of New York LLC. This bulk packaging label includes dosage form, strength, quantity of 100 tablets, storage instructions, and distributor information. The label also features barcodes and cautions about child safety and medication handling.*

FDA Label Image

1 (Orphenadrine Citrate Extended Release Tablets 2)

Label for Orphenadrine Citrate Extended-Release Tablets, 100 mg strength, supplied in a bulk package of 500 tablets. The label includes storage instructions to keep at controlled room temperature (15° to 30°C), and states that the package is child-resistant. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label also includes a barcode and usual dosage advisory to see accompanying prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.